333 related articles for article (PubMed ID: 10101581)
1. Outcome measures in multiple sclerosis clinical trials.
Andersson PB; Goodkin DE
Baillieres Clin Neurol; 1997 Oct; 6(3):409-28. PubMed ID: 10101581
[TBL] [Abstract][Full Text] [Related]
2. Reconsidering clinical outcomes in Multiple Sclerosis: relapses, impairment, disability and beyond.
D'Souza M; Kappos L; Czaplinski A
J Neurol Sci; 2008 Nov; 274(1-2):76-9. PubMed ID: 18817932
[TBL] [Abstract][Full Text] [Related]
3. Methodological problems in evaluating efficacy of a treatment in multiple sclerosis.
Waubant E; Goodkin D
Pathol Biol (Paris); 2000 Mar; 48(2):104-13. PubMed ID: 10815286
[TBL] [Abstract][Full Text] [Related]
4. Scales as outcome measures for Alzheimer's disease.
Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
[TBL] [Abstract][Full Text] [Related]
5. MRI as an outcome in multiple sclerosis clinical trials.
Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome measures in multiple sclerosis.
Amato MP; Portaccio E
J Neurol Sci; 2007 Aug; 259(1-2):118-22. PubMed ID: 17376487
[TBL] [Abstract][Full Text] [Related]
7. The use of MRI as an outcome measure in clinical trials.
Li DK; Li MJ; Traboulsee A; Zhao G; Riddehough A; Paty D
Adv Neurol; 2006; 98():203-26. PubMed ID: 16400836
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.
Simon JH
West J Med; 1996 Jun; 164(6):502-9. PubMed ID: 8764625
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for the conduct of clinical trials for spinal cord injury (SCI) as developed by the ICCP panel: clinical trial outcome measures.
Steeves JD; Lammertse D; Curt A; Fawcett JW; Tuszynski MH; Ditunno JF; Ellaway PH; Fehlings MG; Guest JD; Kleitman N; Bartlett PF; Blight AR; Dietz V; Dobkin BH; Grossman R; Short D; Nakamura M; Coleman WP; Gaviria M; Privat A;
Spinal Cord; 2007 Mar; 45(3):206-21. PubMed ID: 17179972
[TBL] [Abstract][Full Text] [Related]
10. Methodology of clinical trials in multiple sclerosis.
Mitsikostas DD
Neurol Sci; 2006 Sep; 27 Suppl 5():S362-4. PubMed ID: 16998721
[TBL] [Abstract][Full Text] [Related]
11. Magnetic resonance imaging metrics and their correlation with clinical outcomes in multiple sclerosis: a review of the literature and future perspectives.
Bar-Zohar D; Agosta F; Goldstaub D; Filippi M
Mult Scler; 2008 Jul; 14(6):719-27. PubMed ID: 18424478
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging as a surrogate outcome measure of disability in multiple sclerosis: have we been overly harsh in our assessment?
Goodin DS
Ann Neurol; 2006 Apr; 59(4):597-605. PubMed ID: 16566022
[TBL] [Abstract][Full Text] [Related]
13. Defining multiple sclerosis treatment response with magnetic resonance imaging: how much activity is too much?
Giacomini PS; Arnold DL; Bar-Or A; Antel JP
Arch Neurol; 2009 Jan; 66(1):19-20. PubMed ID: 19139295
[No Abstract] [Full Text] [Related]
14. Definition of responder: introduction.
Comi G
Neurol Sci; 2008 Sep; 29 Suppl 2():S209-10. PubMed ID: 18690493
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes assessment in multiple sclerosis.
Rudick R; Antel J; Confavreux C; Cutter G; Ellison G; Fischer J; Lublin F; Miller A; Petkau J; Rao S; Reingold S; Syndulko K; Thompson A; Wallenberg J; Weinshenker B; Willoughby E
Ann Neurol; 1996 Sep; 40(3):469-79. PubMed ID: 8797541
[TBL] [Abstract][Full Text] [Related]
16. Revisiting the multiple sclerosis functional composite: proceedings from the National Multiple Sclerosis Society (NMSS) Task Force on Clinical Disability Measures.
Ontaneda D; LaRocca N; Coetzee T; Rudick R;
Mult Scler; 2012 Aug; 18(8):1074-80. PubMed ID: 22740488
[TBL] [Abstract][Full Text] [Related]
17. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
18. Review of methodological issues of clinical trials in multiple sclerosis.
Montalban X
J Neurol Sci; 2011 Dec; 311 Suppl 1():S35-42. PubMed ID: 22206765
[TBL] [Abstract][Full Text] [Related]
19. Clinical trials in multiple sclerosis.
Cutter G; Kappos L
Handb Clin Neurol; 2014; 122():445-53. PubMed ID: 24507530
[TBL] [Abstract][Full Text] [Related]
20. The use of MR imaging as an outcome measure in multiple sclerosis clinical trials.
Bermel RA; Fisher E; Cohen JA
Neuroimaging Clin N Am; 2008 Nov; 18(4):687-701, xi. PubMed ID: 19068409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
